A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy
Clinical trial NCT02661659 · WITHDRAWN
Trial details
- NCT number
- NCT02661659
- Sponsor
- University of Chicago
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-12
- Primary completion
- 2017-10-03
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.